6 Effective Strategies to Boost Patient Recruitment in Dermatology and Rheumatology Trials
In the ever-evolving landscape of clinical trials, patient recruitment strategies stand as a critical component. The ability to effectively and efficiently recruit patients can significantly impact the success of a trial. This article explores various strategies and tools to enhance dermatology and rheumatology patient recruitment.  1. Corrective Data Mining Corrective database mining significantly contributes to shortening timelines from […]
How to Write First-Rate Protocols for a Psoriasis Study – Focus: Study Design
The success of any clinical study is dependent upon a study protocol; the overall quality of the study depends on this very document. This is especially true for multicenter studies which involve many investigators and clinical staff. This article will explore the best tips to deliver first-rate protocols in psoriasis to set you apart from the competition. […]
Estimands in Clinical Trials
Table of contents Understanding Estimands Application of Estimands in Different Phases of Clinical Research Specifying Estimands for Secondary and Exploratory Endpoints Shared Cross-Functional DutiesâShould estimand be only defined by biostatisticians? Benefits of Preliminary Conversation on Estimands Main Impacts of Statistical Analysis In essence, estimands are not a novel concept to clinical trials. The facets they […]
Europe: Global Clinical Trial Activityâs Prime Location
The European Union (EU) is listed as one of the most desirable regions to conduct a clinical trial and Innovaderm has positioned itself as a pacesetter in the industry for its operational capabilities and experience in conducting studies in this part of the world. Worldâs largest growing market Europeâs 27 countries and 447 million inhabitants is the worldâs largest single market […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study – Focus: CLINICAL ASSESSMENTS AND ENDPOINTS
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Clinical Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, is […]
Dr.âŻRobert Bissonnette and Dr.âŻKim Papp on Shaping the Future of Clinical Research
In collaboration with Probity Medical Research (PMR) For the occasion of the 2023 EADV, Dr. Bissonnette from Innovaderm Research and Dr. Papp from Probity Medical Research (PMR) seized a rare moment to engage in a compelling conversation. These industry leaders share a common journeyâthe conception and evolution of their clinical research companies, which began as local endeavors […]
Backup Plans in Clinical Trials: A Focus on Rheumatology
Rheumatology clinical trials, by their very nature, are unpredictable. Unforeseen complications can arise, threatening the continuity of the trial. This unpredictability underscores the necessity of backup plans. These plans can mitigate risks and ensure the trialâs continuity. The investment level for a proper backup plan is crucial as the potential loss from missed timelines, missed […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study – Focus: STUDY DESIGN
In recent years, dermatologic therapeutics has become a subspecialty of growing interest in the CRO industry, with clinical research in the area focused on a wide range of skin indications such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD)1, also known as atopic eczema, is the most common, long-term type of […]
Enhancing Clinical Performance and Cost Efficiency: The Significance of Protocol Writing in Dermatology Trials
Did you know that protocol amendments are not only common, but also very costly? In fact, as per a recent article by Getz K. et al., 57% of protocols had at least one substantial amendment with an average of 2.3 global amendments for phaseâŻ2 and phaseâŻ3 studies. The cost to implement one protocol amendment was $141,000 US […]
On the Edge of Dermatology Early Phase Trials
Watch this exciting webinar presented by Innovaderm Research in collaboration with Altasciences and be part of: Deep Dive in Study Design Discussion on SAD-MAD-POC Best Practices and Innovations From our early phase experts: Dr. Ana Palijan, Associate Director, Early Phase Department, Innovaderm Research Dr. Beatrice Setnik, Chief Scientific Officer, Altasciences Fareheen Chowdhury, Project Manager, […]
